Trump tries ‘Most Favored Nation’ drug pricing again, this time with Part D
On May 12 the Trump administration announced a revival of the “Most Favored Nation” (MFN) drug pricing executive order (EO) similar to one it unsuccessfully tried to implement in President Trump’s first term. Apart from including Part D drugs and some more aggressive language than last time, administration officials did not immediately say how this attempt would achieve a different result.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.